Holen Sie sich die Stockscreener-App
42.57
1.02%
0.43
Vorhandelsmarkt:
42.90
0.33
+0.78%
Schlusskurs vom Vortag:
$42.14
Offen:
$42.71
24-Stunden-Volumen:
252.05K
Relative Volume:
0.48
Marktkapitalisierung:
$1.96B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$-20.76M
KGV:
-92.54
EPS:
-0.46
Netto-Cashflow:
$151.63M
1W Leistung:
+0.69%
1M Leistung:
-5.84%
6M Leistung:
+48.53%
1J Leistung:
+30.70%
1-Tages-Spanne:
$42.35
$43.34
1-Wochen-Bereich:
$41.36
$43.38
52-Wochen-Spanne:
$25.12
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Vergleichen Sie OMCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
42.57 | 1.96B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
216.59 | 35.16B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
73.51 | 12.70B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
53.72 | 10.03B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
102.42 | 8.88B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.47 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
Automated Dispensing Machines Market 2024-2031: Global - openPR
Arkadios Wealth Advisors Boosts Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Where are the Opportunities in (OMCL) - Stock Traders Daily
Pharmacy Automation Market Size Trends, Regional Dynamics, and Emerging Growth Factors in Key Industries Leading to 2027 - Barchart
Pharmacy Automation Market Generated Opportunities, Future Scope (2024-2031) | Swisslog Healthcare, Omnicell, Inc. - openPR
Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025 - Business Wire
Wells Fargo & Company Cuts Omnicell (NASDAQ:OMCL) Price Target to $40.00 - MarketBeat
Omnicell (OMCL) Introduces Central Med Automation Service - MSN
Pharmacy Automation Market Top Companies Study - openPR
United States Pharmacy Management System Market May See a Big Move | Omnicell, McKesson, GE Healthcare - openPR
Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Marketscreener.com
Omnicell to Present at JP Morgan's Influential Healthcare Conference in January 2025 - StockTitan
Omnicell Gains 26.2% in a Year: What's Driving the Stock? - MSN
Central Fill Pharmacy Automation Market Detailed In New - openPR
Bank of America Cuts Omnicell (NASDAQ:OMCL) Price Target to $46.00 - MarketBeat
Research Analysts Set Expectations for Omnicell Q4 Earnings - MarketBeat
The past three years for Omnicell (NASDAQ:OMCL) investors has not been profitable - Simply Wall St
Pharmacy Automation Market Size, Growth Status to 2033 TOSHO, Takazono, ScriptPro, BD, Baxter, Omnicell - openPR
Principal Financial Group Inc. Cuts Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Analysts Set Omnicell, Inc. (NASDAQ:OMCL) Target Price at $52.00 - MarketBeat
Omnicell (NASDAQ:OMCL) Trading Down 2.4%What's Next? - MarketBeat
Omnicell (NASDAQ:OMCL) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Jane Street Group LLC Has $2.20 Million Stock Holdings in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories - Zacks Investment Research
4 Healthcare Technology Innovators to Invest in Before the New Year - Zacks Investment Research
Why Omnicell (OMCL) Might be Well Poised for a Surge - MSN
Medication Management Market (2024-2032): Industry Insights, - openPR
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles By Investing.com - Investing.com Australia
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles - Investing.com
Don't Ignore The Insider Selling In Omnicell - Simply Wall St
Wellington Management Group LLP Sells 1,148,356 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell director Mark Parrish sells shares worth $567,638 By Investing.com - Investing.com Australia
Omnicell, Inc. (NASDAQ:OMCL) Short Interest Update - MarketBeat
Omnicell partners with Gollmann to expand pharmacy automation solutions - Pharmacy Business
Omnicell director Mark Parrish sells shares worth $567,638 - Investing.com India
Centiva Capital LP Sells 19,341 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 643,292 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Director Mark Parrish Sells 12,000 Shares of Omnicell Inc (OMCL) - GuruFocus.com
What Makes Omnicell (OMCL) a New Strong Buy Stock - MSN
Omnicell Introduces OmniSphere Platform, Stock to Gain - MSN
Future-Proofing Growth of Medication Management - openPR
LSPedia AND OMNICELL COLLABORATE IN AN EFFORT TO ADVANCE PHARMACY SUPPLY CHAIN COMPLIANCE AND INNOVATION FOR HOSPITALS AND HEALTH SYSTEMS - The Eastern Progress Online
Central Fill Pharmacy Automation Market Emerging Trends and Growth Prospects 2032 |Omnicell, McKesson, Swisslog - openPR
Omnicell (NASDAQ:OMCL) Stock Rating Lowered by StockNews.com - Defense World
Omnicell (NASDAQ:OMCL) Lowered to "Hold" Rating by StockNews.com - MarketBeat
Pharmacy Dispensing Automation Market Likely to Boost Future Growth by 2031: McKesson, Omnicell, Cerner - openPR
Omnicell Announces OmniSphere - Business Wire
Central Fill Pharmacy Automation Market Projected To Witness Substantial Growth, 2024-2031: ARxIUM Inc., - EIN News
Pier Capital LLC Buys New Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):